The UK government has outlined how it will ensure the supply of medicines continues in the event of a “no deal” Brexit, urging companies to stockpile six weeks' worth of medicine.<
AstraZeneca has said it is analysing “inconsistent” results after a late-stage trial of its Bevespi Aerosphere inhaler in chronic obstructive pulmonary disease (COPD) failed to match the pe
Bayer has issued a robust defence of Essure after the birth control implant was featured in The Bleeding Edge, a Netflix documentary about the medical devices industry.
Janssen has won US approval for its once-daily HIV pill Symtuza (D/C/F/TAF), which it hopes will improve patient adherence and resistance to treatment.